iTonic Holdings Ltd

ITOC ·Healthcare, Medical Devices
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022
Revenue $523.0K $448.2K $628.6K $679.8K
Cost of Revenue $195.7K $67.0K $157.8K $121.6K
Gross Profit $327.4K $381.2K $470.8K $558.2K
Gross Margin 62.6% 85.0% 74.9% 82.1%
Operating Expenses
Research & Development $459.1K $93.3K $84.5K $73.7K
SG&A Expense $4.9M $750.6K $424.9K $162.1K
Operating Income $-5.2M $-770.3K $-306.7K $27.5K
Operating Margin -991.7% -171.9% -48.8% 4.0%
Interest Expense
Pretax Income $-5.1M $-638.8K $-260.5K $71.0K
Income Tax Expense $21.8K $-19.3K $-13.0K
Net Income $-5.1M $-660.6K $-241.2K $84.0K
Net Margin -974.7% -147.4% -38.4% 12.4%
EPS (Basic) $-0.32 $-0.05 $-0.02 $0.01
EPS (Diluted) $-0.32 $-0.05 $-0.02 $0.01
Shares Outstanding (Basic) 16.0M 12.7M 12.0M 12.0M
Shares Outstanding (Diluted) 16.0M 12.7M 12.0M 12.0M
Dividends Per Share